Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. - sprookjes - yvandenbroek - TriplyDB

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

http://www.wikidata.org/entity/Q30430034

about

Early detection of diabetic kidney disease: Present limitations and future perspectives Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications Perspectives on systems biology applications in diabetic kidney disease Proteomic candidate biomarkers of drug-induced nephrotoxicity in the rat Applying computation biology and "big data" to develop multiplex diagnostics for complex chronic diseases such as osteoarthritis Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to enzyme replacement therapy Urinary proteomics to support diagnosis of stroke Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: a multicentric study Doping control using high and ultra-high resolution mass spectrometry based non-targeted metabolomics-a case study of salbutamol and budesonide abuse Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice Seminal plasma as a source of prostate cancer peptide biomarker candidates for detection of indolent and advanced disease Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy The role of laboratory testing in detection and classification of chronic kidney disease: national recommendations Misclassification Errors in Unsupervised Classification Methods. Comparison Based on the Simulation of Targeted Proteomics Data.Classical MALDI-MS versus CE-based ESI-MS proteomic profiling in urine for clinical applications.Application of Proteomic Analysis to Renal Disease in the Clinic.Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of Disease Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria Deciphering the peptidome of urine from ovarian cancer patients and healthy controls.Addressing the challenge of defining valid proteomic biomarkers and classifiers.Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases Proteomic analysis of urinary upper gastrointestinal cancer markers.Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy.Identification of urinary peptide biomarkers associated with rheumatoid arthritis.Capillary zone electrophoresis-electrospray ionization-tandem mass spectrometry for quantitative parallel reaction monitoring of peptide abundance and single-shot proteomic analysis of a human cell line.Analysis of the urine proteome via a combination of multi-dimensional approaches.Mass spectrometry in chronic kidney disease research.CE-MS for the analysis of intact proteins 2010-2012.Defining nephrotic syndrome from an integrative genomics perspective.Protein glycation in diabetes as determined by mass spectrometry.Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine.CKD273, a new proteomics classifier assessing CKD and its prognosis The Human Urinary Proteome Fingerprint Database UPdb.

P2860

Q26741494-493352E7-FF5F-4DFD-8B06-CB0824355FE4 Q26747131-7D81B93F-3D3F-40D1-9270-71EFB8DACF0D Q26752555-A38F3E3D-265C-45B9-8897-3560C7342F49 Q26769678-2A7405DA-D786-4D01-8A7C-79253CE954D3 Q26823206-E0E41DA6-A870-4DC8-B62F-E090193047B3 Q27305109-D11D255B-3C55-46A4-BC34-9916941E256E Q28076074-74C69DB0-3443-4147-8481-6F222EA876FE Q28475613-19BDA4E8-2CA9-4394-984A-A638C8607B09 Q28477629-B6F3322E-CC1B-44F0-8F31-4BBA558ACB83 Q28478586-AA5562ED-6C0E-4B02-B469-77972B642979 Q28483776-21D4A7CD-68BF-4607-AB9C-B6F8F782167F Q28484239-12D04BB0-E038-4D42-86CC-963EB780FA8D Q28484968-86C90012-B04E-4B1F-9B23-E84A694B5422 Q28533600-0CCD7AE1-5559-4ADD-ABF2-CECDE95B9ABF Q28533986-BBBA2C6B-6757-4456-8913-34F4CB65B254 Q28534010-C64FCBBE-E445-4BD0-9C57-E8DA76F5ACB3 Q28534235-674C3BE6-CF2F-4660-B7DC-40A2165CB6F4 Q28748796-05104865-4725-418C-8614-5C2D3946DF43 Q30234884-AC414CD9-C191-476C-B613-5516BDBBD4EA Q31121694-F1DEC66C-6B6C-403E-9D48-E8F119510ADF Q31148183-83183014-A266-4DA9-A15F-DC90E5542C5B Q33575004-4411E849-E6DD-4A22-8991-AC8DD95CBFBC Q33591146-B72909CD-29A2-4990-B79D-ED6BF6890EB4 Q33597457-7F69EA5D-54F4-4211-81DE-37F2DCB7BCD9 Q33735287-F981F311-4AF0-413A-BFA7-2B8EB2023374 Q33786098-0DD0E03A-7DA0-4F61-A2C0-517F4BD7C463 Q33786157-653097A9-27F4-43E1-B4B3-E7837201954C Q33838866-BD245357-EB69-491B-9FBF-4C7C1A193A8B Q33888474-3D8AA9C8-36CF-40AE-A268-C8BB0D3D8E5C Q33985444-53035CDB-070A-4A55-83FD-32DEF251A8C3 Q34075303-A3DB7235-05E2-46B9-B2B6-7A1775592B18 Q34079270-64030B90-F414-4946-9532-5A57A513E45B Q34090618-C72A8258-F64E-4BD3-9670-BE814A0A0C72 Q34313959-B7B73BF3-337A-4F05-9A9C-2D916589815B Q34480662-0AF2095C-086B-4932-BA21-6D19403AA2AA Q34560989-9386D1F1-DF6A-460D-BA06-127010FEDB57 Q34661579-A77C0199-64BE-47DB-B2E8-20815BD5E84D Q34691573-239BFF4F-56D9-4258-B709-BEA60A493E15 Q34729912-4E8701B8-229E-43FF-A524-0653CEC214E6 Q35040000-C23640A1-48AB-4BA1-8D60-694208C0AE49

P2860

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

http://www.wikidata.org/entity/Q30430034

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Naturally occurring human urin ...... sis of chronic kidney disease.

@ast

Naturally occurring human urin ...... sis of chronic kidney disease.

@en

type

label

Naturally occurring human urin ...... sis of chronic kidney disease.

@ast

Naturally occurring human urin ...... sis of chronic kidney disease.

@en

prefLabel

Naturally occurring human urin ...... sis of chronic kidney disease.

@ast

Naturally occurring human urin ...... sis of chronic kidney disease.

@en

P1433

Q30430034-974935D6-8EC5-4138-B233-EDE87CA42422

P1476

Q30430034-DC15E58D-7237-4714-8968-183EE019ED0F

P2093

Q30430034-1074080C-2654-46BD-80D5-C7059433425B

Q30430034-113C508A-E3F9-4C1F-A999-31AD9312B34F

Q30430034-21C495F0-B4EB-42BD-8629-FD569AB1C777

Q30430034-2667C743-6D8F-4FEE-B136-862AD79C76D5

Q30430034-279102A8-3110-48D1-A93B-1D1EE4A95C2C

Q30430034-27CC57E2-EFED-4FF9-B8B2-BC18DA583155

Q30430034-34C5ABDE-B696-43A4-A91D-EAAB47CB8944

Q30430034-42467019-53F1-4CFC-95C5-4D71EF554F64

Q30430034-451E9527-19D6-4132-B2E9-881E937EBACB

Q30430034-4DB68E93-526C-4C28-A584-C932082140FF

P2860

Q30430034-044D4200-88CA-4580-BC18-790313F17CAE

Q30430034-05348631-C6C3-493E-8EFA-53797ADB1F2A

Q30430034-08158750-3542-4B52-AF9E-141AF1B953DB

Q30430034-0A4FBC1C-C624-421F-AF61-1BB2C14FCB8B

Q30430034-0B1F5365-A278-4255-B31D-5052C03BB3DA

Q30430034-0E37AD9B-5DB3-4EC8-9E5F-89CCE291D5E2

Q30430034-0EBE7D0E-CDF2-4C4E-9301-E4BA3FB03346

Q30430034-0FC53F72-640B-4C1D-ADDC-3C2C64DEF25B

Q30430034-1AC634C3-F4E1-443D-B1E1-1F77C6B2A0E6

Q30430034-1B6C6AAA-68B7-45E5-8C6A-5B23D741AF5F

P304

Q30430034-482CF751-4E49-46EA-BCEB-84008BEA1710

P31

Q30430034-F12BA38F-6044-4F48-B535-83B0E93EB216

P356

Q30430034-E5554023-31E6-458B-B51C-2961EC2841D0

P433

Q30430034-05558D6B-82A1-488A-97CC-1D8B75AF3208

P478

Q30430034-201F064D-4A7A-4D33-BA2C-D41E054F366E

P50

Q30430034-059D89C1-A2F0-4367-AA68-96747C1A23AE

Q30430034-1F728E27-47F0-4C5C-9EB1-9721BE2F02A2

Q30430034-457FDC7F-5C65-452B-B234-6176ABD55E0B

Q30430034-58867753-C751-4F45-9302-57EFBCD1A2C3

Q30430034-621580EF-0209-436F-898B-47576DDD0C1E

Q30430034-724B07F0-AD1A-4BDB-8AE5-9F539C2E63F1

Q30430034-8921CB53-5C1D-43C7-861F-88CB9331195C

Q30430034-8B5106D5-4A69-4DCB-A5DA-4831A2FF28BF

Q30430034-B96F6BD4-797A-4652-AD8A-B5D9971AD0A2

Q30430034-BB3DD745-A029-4131-BF3F-EB4AB4142BB6

P577

Q30430034-21C59600-841C-471C-8553-5F77CD4EF2BD

P5875

Q30430034-25DEF19B-6568-4025-A6C1-B777972B09B8

P698

Q30430034-A739D335-7B91-4830-A10B-5426D388AB0D

P932

Q30430034-EC6A7C03-AFB0-4951-B1FD-6A0804E01FBB

P356

MCP.M110.001917

P1433

Molecular & Cellular Proteomics

P1476

Naturally occurring human urin ...... sis of chronic kidney disease.

@en

P2093

Andrzej S Krolewski

http://www.w3.org/2001/XMLSchema#string

Angel Argilés

http://www.w3.org/2001/XMLSchema#string

Arnold Ganser

http://www.w3.org/2001/XMLSchema#string

Bruce A Julian

http://www.w3.org/2001/XMLSchema#string

Christian Delles

http://www.w3.org/2001/XMLSchema#string

Christian Neusüss

http://www.w3.org/2001/XMLSchema#string

Dan Theodorescu

http://www.w3.org/2001/XMLSchema#string

Danilo Fliser

http://www.w3.org/2001/XMLSchema#string

David M Good

http://www.w3.org/2001/XMLSchema#string

Eric Schiffer

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Identification and proteomic profiling of exosomes in human urine

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry.

Significance analysis of microarrays applied to the ionizing radiation response

Performance characteristics of electron transfer dissociation mass spectrometry

The minimum information about a proteomics experiment (MIAPE)

Identification and validation of urinary biomarkers for differential diagnosis and evaluation of therapeutic intervention in anti-neutrophil cytoplasmic antibody-associated vasculitis

Electron transfer dissociation of peptide anions.

Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine.

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.

P304

2424-2437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.M110.001917

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Christian Delles

Karlheinz Peter

Anna Dominiczak

Raymond Vanholder

Joost P Schanstra

P577

2010-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45113726

http://www.w3.org/2001/XMLSchema#string

P698

20616184

http://www.w3.org/2001/XMLSchema#string

P932

2984241

http://www.w3.org/2001/XMLSchema#string